Role of Vitamin D in pain relief in Rheumatoid Arthritis
Not Applicable
- Conditions
- Health Condition 1: null- Newly diagnosed (less than 2 years) patients of Rheumatoid Arthritis
- Registration Number
- CTRI/2018/01/011532
- Lead Sponsor
- Dr Dibyendu Mukherjee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed Rheumatoid Arthritis (duration less than 2years) subjects, who have not been treated with any medication other than analgesics prior to study recruitment.
Exclusion Criteria
(i) patients who have been on steroids during the past year; (ii) known to have disorders of calcium metabolism such as malabsorption, hyperparathyroidism, chronic renal failure, renal tubular acidosis or pancreatitis; (iii) known allergy to DMARDs, 1,25 dihydroxy vitamin D3 or calcium; (iv) patients unlikely for follow-up in the following 8 weeks; (v) patients unable to afford triple DMARD therapy; (vi) patients who were suspected to have vasculitis; (vii) and patients unable to mark the pain scale.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Minimum time (days) required for onset of pain relief (Tm)Timepoint: From study onset to end of 2 months
- Secondary Outcome Measures
Name Time Method %change in visual analogue score (VAS) score from baseline.Timepoint: From study onset to end of 2 months